Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies.
about
ZZ domain of dystrophin and utrophin: topology and mapping of a beta-dystroglycan interaction siteAnalysis of Dystrophin Gene Deletions by Multiplex PCR in Moroccan PatientsThe importance of genetic diagnosis for Duchenne muscular dystrophyClinical features of patients with dystrophinopathy sharing the 45-55 exon deletion of DMD geneAnimal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapyMolecular biology of neurological diseases.Two novel missense mutations in the myostatin gene identified in Japanese patients with Duchenne muscular dystrophy.Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers.Cosegregation of schizophrenia with Becker muscular dystrophy: susceptibility locus for schizophrenia at Xp21 or an effect of the dystrophin gene in the brain?Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups.Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients.Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis.Dystrophin analysis in idiopathic dilated cardiomyopathy.Deletions in the 5' region of dystrophin and resulting phenotypes.Dilated cardiomyopathy and the dystrophin gene: an illustrated reviewAnalysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy.MLPA identification of dystrophin mutations and in silico evaluation of the predicted protein in dystrophinopathy cases from India.Clinical and molecular characterization of a cohort of patients with novel nucleotide alterations of the Dystrophin gene detected by direct sequencingComputational study of the human dystrophin repeats: interaction properties and molecular dynamics.Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx miceImmunohistochemical analysis of dystrophin-associated proteins in Becker/Duchenne muscular dystrophy with huge in-frame deletions in the NH2-terminal and rod domains of dystrophinDeficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin.Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice.In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse.A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy.A comprehensive database of Duchenne and Becker muscular dystrophy patients (0-18 years old) in East ChinaDetection limit of intragenic deletions with targeted array comparative genomic hybridization.Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.Quadriceps myopathy caused by skeletal muscle-specific ablation of β(cyto)-actinInterplay between DMD point mutations and splicing signals in Dystrophinopathy phenotypes.Induction of revertant fibres in the mdx mouse using antisense oligonucleotidesCurrent status of pharmaceutical and genetic therapeutic approaches to treat DMD.Duchenne muscular dystrophy gene therapy: Lost in translation?Mutational analysis of patients with adenomatous polyposis: identical inactivating mutations in unrelated individuals.Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45.Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy.Enhancing translation: guidelines for standard pre-clinical experiments in mdx miceAre cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localization?Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trialsDuchenne muscular dystrophy gene therapy in the canine model.
P2860
Q24672189-F5F83CB9-5C8E-4B87-8022-E7D40B87D186Q24801630-3593C1C9-E09F-4CC6-B1C9-6243D2C5C112Q26769701-8C731CA7-1CAA-4E7B-B9CB-5ED0064AB5B7Q27011968-60028086-2EA9-45B5-B7E6-641115BACCB4Q28084979-242E9BBE-2C55-4732-BB94-4A78994247E1Q30493405-5F9B5371-C31D-49E1-8EDA-D057F0BE091CQ33281832-AD07F2B7-D610-4217-A312-2CA8265AEE5EQ33573648-E4CC81B6-1BC3-4A8F-B10F-28CB91EA18DDQ33594985-3556D701-56AA-4A84-85FF-632E58D21644Q33595755-40FD44FD-789B-4839-B43D-59511EECDEEFQ33595762-F48AD9A8-D3C6-495E-B921-197FA743952BQ33595768-E5A098D7-A03D-4353-93B9-BC2309FA71F1Q33596006-A8C8E987-37FF-4063-93C8-CD62489772F0Q33596173-92EA591F-69AC-4DA9-A1CE-87AF2F2E0CB1Q33614191-7A65D55D-F451-4433-946D-3FEB81A926BEQ33680612-008FA4E0-F0BE-4860-B1DE-95731C543A88Q33796134-4D23646C-F603-423B-852D-7F392005EB2CQ33843901-6E746301-6EB1-4E8D-8763-D7A8E2C122D0Q34013751-DD079B0B-478F-445F-9F39-BEC1A9FE9E0CQ34025748-5B4CE03F-2260-4709-BC22-1777A52CBBC3Q34119276-F7A595B9-5131-415C-A92B-DAFF4C3331FAQ34171331-1D8DAAD8-8F79-4544-821A-184938242581Q34194689-6B60E773-CB11-49B1-A9E9-A849B675A925Q34343780-1783948C-D155-4849-B867-63D923192D21Q34443876-85B80219-9D9F-4040-8B7D-6EEF542EF0D4Q34459245-CDE9F65B-DB7D-4C3B-9C6D-80280FE91AF5Q34530570-BBDC511A-F2ED-4505-871D-9DC2D0E68CD4Q34566454-EF28780E-EE91-461D-AC28-F3C521C777F8Q34625134-FED9C9C2-ACEC-4424-9D4F-6F5601214A73Q34639835-58C7DD4C-81B6-4536-8328-DFD47C03BDC2Q34691050-7364775B-BFF9-4016-BBB6-06DC004EB5F4Q34994545-1F545073-F735-479B-A80C-CBD5DFF34E64Q35052506-5BA4509E-DD80-4FBC-A3DD-9CD8ABE23B74Q35194454-DC9275F2-7051-4088-A84D-E9CFDA5F4322Q35224393-EB61C2E5-33D6-44BF-BB8D-4DDB3251DF2AQ35582668-632E6553-B3CD-40DD-ACB7-CB8D2C5FFB3DQ35583176-F806286E-9752-443C-B704-A3BA4F9DE6ACQ35598514-5C592C29-1F87-49C2-899D-AFD6E6F0DBE8Q35606737-C2AA790A-0D7B-4CD4-B404-1C9463047B5AQ35641673-8BB8602C-3FE3-4FFC-902D-5FF4CAB25203
P2860
Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies.
description
1991 nî lūn-bûn
@nan
1991 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Exploring the molecular basis ...... phin gene and protein studies.
@ast
Exploring the molecular basis ...... phin gene and protein studies.
@en
type
label
Exploring the molecular basis ...... phin gene and protein studies.
@ast
Exploring the molecular basis ...... phin gene and protein studies.
@en
prefLabel
Exploring the molecular basis ...... phin gene and protein studies.
@ast
Exploring the molecular basis ...... phin gene and protein studies.
@en
P2093
P2860
P1476
Exploring the molecular basis ...... phin gene and protein studies.
@en
P2093
C Angelini
E P Hoffman
J R Snyder
L M Kunkel
P2860
P407
P577
1991-07-01T00:00:00Z